![](/img/cover-not-exists.png)
5.29 Potential of AFX-2, a Unique, Polysaccharide-Based Toll-like Receptor Agonist, in Patients With Chronic Lymphocytic Leukemia
Stephen M. Sagar, Kevin P. High, Edward G. Shaw, Christine Lutsiak, Sharla Sutherland, Jacqueline ShanVolume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.clml.2011.09.183
File:
PDF, 93 KB
english, 2011